Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × Counseling × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 9 Neoplasms 4 Overweight 3 Obesity 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Sleep Wake Disorders 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Leukemia 2 Hematopoietic and Lymphoid System Neoplasm 2 Hematologic Neoplasms 2 Fatigue 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Obesity-Related Malignant Neoplasm 1 No Evidence of Disease 1 Neoplasm Metastasis 1 Motor Activity 1 Metastatic Pancreatic Adenocarcinoma 1 Leukemia, Myeloid, Acute 1 Intermittent Fasting 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Carcinoma 1

Interventions

Cyclophosphamide 7 Biopsy 6 romidepsin 5 mogamulizumab 5 fludarabine 5 Brentuximab Vedotin 5 pembrolizumab 4 fludarabine phosphate 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 ruxolitinib 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Depsipeptides 3 hypericin 2 belinostat 2 Whole-Body Irradiation 2 Tacrolimus 2 Melphalan 2 Lactones 2 Etoposide 2 Busulfan 2 Bexarotene 2 trastuzumab biosimilar HLX02 1 tofacitinib 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡